Nisa Investment Advisors LLC Purchases New Shares in Revvity, Inc. (NYSE:RVTY)

Nisa Investment Advisors LLC bought a new position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 78,397 shares of the company's stock, valued at approximately $8,570,000. Nisa Investment Advisors LLC owned approximately 0.06% of Revvity as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the stock. Gladius Capital Management LP boosted its position in shares of Revvity by 84.1% during the third quarter. Gladius Capital Management LP now owns 232 shares of the company's stock worth $26,000 after buying an additional 106 shares during the period. CENTRAL TRUST Co acquired a new stake in shares of Revvity in the fourth quarter valued at approximately $27,000. JTC Employer Solutions Trustee Ltd bought a new stake in shares of Revvity in the fourth quarter worth $33,000. Headinvest LLC acquired a new position in Revvity during the third quarter worth $57,000. Finally, DB Wealth Management Group LLC bought a new position in Revvity in the fourth quarter valued at $79,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Stock Performance

Revvity stock traded down $2.82 during trading hours on Wednesday, hitting $107.90. The company had a trading volume of 1,439,235 shares, compared to its average volume of 826,945. Revvity, Inc. has a one year low of $79.50 and a one year high of $139.04. The firm has a market cap of $13.33 billion, a PE ratio of 19.62, a PEG ratio of 2.77 and a beta of 1.09. The firm has a 50-day moving average of $105.13 and a 200 day moving average of $101.95. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.07 and a quick ratio of 1.77.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.10. The company had revenue of $695.90 million for the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. On average, sell-side analysts expect that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be paid a $0.07 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.26%. Revvity's dividend payout ratio (DPR) is presently 5.09%.

Insider Buying and Selling

In other news, insider Prahlad R. Singh sold 21,217 shares of Revvity stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total value of $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares in the company, valued at $9,677,288.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have commented on RVTY. Raymond James boosted their price target on shares of Revvity from $106.00 to $127.00 and gave the stock an "outperform" rating in a research report on Friday, February 2nd. Barclays raised their price target on Revvity from $92.00 to $105.00 and gave the company an "equal weight" rating in a research note on Thursday, January 25th. Stifel Nicolaus increased their price objective on Revvity from $95.00 to $110.00 and gave the company a "hold" rating in a report on Friday, February 2nd. Evercore ISI raised shares of Revvity from an "in-line" rating to an "outperform" rating and raised their target price for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Finally, KeyCorp boosted their price objective on shares of Revvity from $110.00 to $126.00 and gave the stock an "overweight" rating in a research note on Friday, February 2nd. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Revvity presently has a consensus rating of "Moderate Buy" and a consensus price target of $118.91.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.